As of Feb 03, 2025, Aadi Bioscience, Inc. Intrinsic Value is $52.4. This suggests it may be undervalued by 1,814.0% compared to its current price of around $2.7.
As of Feb 03, 2025, Aadi Bioscience, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $91.9. This suggests it may be overvalued by 3,255.7% to its current price of around $2.7, using a discount rate of 7.7% and terminal growth rate of 3.0%.
Aadi Bioscience, Inc. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $52.4, compared to a market price of around $2.7. This suggests a potential undervaluation of 1,814.0%.